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Abstract
Background: Weight loss in patients with Alzheimer’s disease (AD) is a common clinical manifestation that may
have clinical significance.
Objectives: To evaluate if there is a difference between nutrition education and oral nutritional supplementation
on nutritional status in patients with AD.
Methods: A randomized, prospective 6-month study which enrolled 90 subjects with probable AD aged 65 years
or older divided into 3 groups: Control Group (CG) [n = 27], Education Group (EG) [n = 25], which participated in
an education program and Supplementation Group (SG) [n = 26], which received two daily servings of oral
nutritional supplementation. Subjects were assessed for anthropometric data (weight, height, BMI, TSF, AC and
AMC), biochemical data (total protein, albumin, and total lymphocyte count), CDR (Clinical Dementia Rating), MMSE
(Mini-mental state examination), as well as dependence during meals.
Results: The SG showed a significant improvement in the following anthropometric measurements: weight (H calc =
22.12, p =< 0.001), BMI (H calc = 22.12, p =< 0.001), AC (H calc = 12.99, p =< 0.002), and AMC (H calc = 8.67, p =<
0.013) compared to the CG and EG. BMI of the EG was significantly greater compared to the CG. There were
significant changes in total protein (H calc = 6.17, p =< 0.046), and total lymphocyte count in the SG compared to
the other groups (H cal = 7.94, p = 0.019).
Conclusion: Oral nutritional supplementation is more effective compared to nutrition education in improving
nutritional status.
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Background
Weight loss in patients with Alzheimer’s disease (AD) is a
common clinical manifestation. In these patients, impaired
nutritional status results in changes in body composition
and biochemistry indicators [1]. In order to identify such
weight loss, some studies correlated organic deficiency
and low energy intake or hypercatabolism in patients, thus
suggesting that weight loss may be a risk factor in the
etiology of dementias and other psychiatric and cognitive
disorders, however this has not been evaluated [2-4].
Higher infection rates, increased energy expenditure due
to repetitive movements, and cognitive deficit impairing
AD patient independence may also be considered as a
cause of weight loss [5,6]. Weight loss increases the risk
for infections, pressure ulcer development and poor
wound healing, which in turn can impair AD patient’s
quality of life [7].
Some strategies can be adopted to improve the nutri-
tional status of these patients. These strategies include
patient nutrition education programs, and the use of oral
nutritional supplements, which can significantly impact
nutritional status [8-10]. Thus, the need to study strategies
of nutritional intervention which minimize or improve AD
patients’ nutritional status is justified, supporting the
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conduction of this study. The objective of this study is to
determine if there is any difference between oral nutri-
tional supplementation and nutrition education on the
nutritional status of patients with AD.
Methodology
A randomized, 6-month, prospective study was conducted
at the clinic of the Behavioral Neurology Sector, in the
Neurology and Neurosurgery Department of Universidade
Federal de São Paulo - Escola Paulista de Medicina (UNI-
FESP/EPM).
The sample consisted of 90 subjects, of both genders,
aged at least 65 years old and with probable AD,
according to Diagnostic Statistical Manual 4th Edition
(DSM IV) criteria and clinical dementia rating (CDR) of
1, 2 or 3.
For exclusion criteria were considered other forms of
dementia, alternative feeding requirement (tube feeding),
type 1 and 2 diabetes mellitus, and renal diseases.
Twelve subjects were included in the study but not in
the statistical analys is: 3 subjects from CG and 4 from
EG had difficulty in being transported to the hospital; 3
subjects from SG and 1 from CG died; 1 subject from SG
needed tube feeding.
The remaining subjects were randomized into 3 groups:
control group (CG), (N = 27), education group (EG), (N =
25), and supplementation group (SG), (N = 26).
All subjects were assessed at baseline and then at
monthly intervals during the 6-month study period,
including an orientation of health nutrition. The subjects
nutritional status was assessed using anthropometric and
biochemical data. The anthropometric data included:
height (m), current weight (kg), Body Mass Index (BMI)
(kg/m2), arm circumference (AC) (cm), arm muscle cir-
cumference (AMC) (cm), and triceps skinfold (TSF)
(mm). For weight were used Welmy® mechanical scales
for adults with a 150 kg capacity and for height was uti-
lized stadiometer graduated in centimeters, to for sub-
jects that were able to maintain erect posture. For the
others with presented posture problems as kyphosis or
lordosis and were usable to stand, the stature and knee
equation proposed by Chumlea (1985) [11] was used, to
avoid biases in measures of statures. For the compart-
mental muscle and fat mass assessment, Lange® Skinfold
calipers were used, which expresses results in millimeters
(mm). The biochemistry data included: total protein
(TP), serum albumin and total lymphocyte count (TLC).
Biochemical data were collected following a 12-hour fast
and evaluated by the central laboratory of Hospital São
Paulo.
For cognitive tracking, all subjects were assessed using
the Mini-Mental State Examination (MMSE) assessing
temporal and spatial orientation, memory, attention,
calculation, language and praxis [12,13] and Clinical
Dementia Rating (CDR) [14,15] administered by a duly
qualified neuropsychologist.
The following demographic data were also collected
for all subjects: education level (years of schooling), time
of disease evolution calculated from the date of diagno-
sis and dependence during meals.
Subjects in the CG were monitored by monthly nutri-
tional assessments and did not receive any form of inter-
vention. The 25 Subjects caregivers and patients, in the EG
participated in the educational program which consisted of
10 classes. Each class was taught to a maximum of 10
participants, with the aim greater interaction between the
professional and caregivers. Each expositive class was sup-
ported by slides, with themes were of data proposed in
accordance with the Brazilian Association of Alzheimer’s
(ABRAZ) Caovilla & Canineu (2002) [16] a nonprofit asso-
ciation that assists caregivers and family members of
patients with Alzheimer’s disease. Also it took into account
the information received from the caregivers based on the
main nutrition deficits in AD patients. The classes were
developed with relevant topics to the needs of nutritional
intervention, such as: the importance of nutrition in dis-
ease, behavioral changes during meals, attractive meals,
constipation, hydration, administration of drugs, swallow-
ing, food supplementation, lack of appetite, clarification of
doubts. This order of exposition follows the progression of
AD and the onset of symptoms that may be related to
nutrition. Subjects in the SG received oral nutritional sup-
plementation twice daily for 6 months in addition to their
usual diet (Ensure with FOS®, Abbott Nutrition) and were
measured monthly by means of anthropometry and bio-
chemical parameters, as described before. Two servings
provide 680 kcal and 25.6 g protein/day.
All subjects or their representatives signed the
Informed Consent Form. This research was approved by
the Ethics Committee of Universidade Federal de São
Paulo (protocol 0552/06).
Statistical analysis was undertook using Kruskal-Wallis
variance analysis to compare the three groups in relation
to anthropometric, biochemistry, demographic and disease
stage variables, and Siegel’s chi-square test to study possi-
ble associations between the groups and the variables stu-
died. The rejection level of the null hypothesis was fixed at
a = 0.05.
Results
Ninety (90) subjects were enrolled in the study, and
86.67% (n = 78) completed the study. Of the subjects,
30% (n = 27) were in the CG; 27.78% (n = 25) were in
the EG; and 28.88% (n = 26) were in the SG. 8.89% (n =
8) of the patients did not meet the inclusion criteria and
4.44% (n = 4) died.
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Of the 78 subjects who completed the study, 67.9%
(n = 53) were female and 32.1% (n = 25) were male,
with mean age of 75.2 years and median age of 76 years.
As shown in tables 1 and 2, 39.7% (n = 31) were in the
moderate phase of the disease (CDR 2) and had a mean
MMSE of 12.32, however there were no statistically signifi-
cant differences among the groups. Demographic data
(table 1) as well as dependence during meals (table 2)
were also not statistically different among the groups. All
these variables show that the groups were similar and did
not have any influence on the results obtained.
Regarding the anthropometric and biochemical para-
meters (Table 3), the SG showed a significant improve-
ment in the anthropometric data of weight (H calc =
22.12, p =< 0.001), body mass index (H calc = 22.12,
p =< 0.001), arm circumference (H calc = 12.99, p =
0.002), and arm muscle circumference (H calc = 8.67,
p = 0.013) compared to CG and EG after 6 months.
There were no statistically significant differences in TSF
among the three groups after 6 months. The BMI in the
EG was significant compared to CG. There were signifi-
cant differences in total protein (H calc = 6.17, p =
0.046) in the SG compared to the other groups. The
total lymphocyte count in the SG and EG was signifi-
cant compared to the CG (H cal = 7.94, p = 0.019) after
6 months.
There were no statistically significant differences in
serum albumin among the three groups.
Discussion
Most subjects studied had CDR 2, which is relevant since
most feeding behavior changes, such as forgetfulness or
feeding voracity, are seen in this phase of the disease [17].
In the EG, BMI showed a significant increase compared
to CG (p < 0.001). Likewise, biochemical (TP and TLC,
p = 0.046, p = 0.019 respectively) and anthropometric
indicators (AC and AMC, p = 0.002 and p = 0.013 respec-
tively) also improved in EG group. Our results support the
findings from other studies, showing that nutritional edu-
cation has a positive effect on the diet and modifies nutri-
tion knowledge [18,7,19].
There were significant differences in the SG’s anthro-
pometric measures (current weight, BMI, AC, AMC)
compared to CG and EG, showing that the use of oral
nutritional supplementation improves the patient ’s
nutritional status. In addition, since there were no sig-
nificant differences in TSF measurement among the
three groups, and particularly in the SG, showed that
there was no increase in subcutaneous body fat. Further-
more, the oral nutritional supplementation did not
result in significant difference in TSF measurement
among the three groups, indicating that additional oral
nutritional supplementation did not increase subcuta-
neous body fat in this sample.
Oral nutritional supplementation provided to demen-
tia patients significantly improves nutritional status and
the quality of the diet consumed [20,21], but despite
these results, Trelis & López [22] observed that only
11% of outpatients used oral nutritional supplements.
In Brazil, there are no studies of outpatients using any
type of oral nutritional supplements. However, this study
clearly indicates that it is important for all health care pro-
fessionals involved in the treatment of patients with AD to
be able to detect the presence of nutritional deficits. This
enables health care professionals to refer the patient to a
qualified health professional, so the best nutritional inter-
vention can be implemented.
The benefits of using oral nutritional supplementation
have also been studied in elderly subjects without demen-
tia and have shown their efficacy in addition to usual diet.
Table 1 Demographic and MMSE data of Alzheimer’s Disease (AD) patients, according to Control Group (CG),
Education Group (EG) and Supplementation Group (SG)
Control Education Supplementation Kruskal-Wallis variance analysis
Mean Median Mean Median Mean Median Calculated H P Significance
MMSE 12.59 18.00 12.80 12.00 11.58 9.00 0.14 0.932 N.S.
Age 75.22 74.00 75.88 76.00 76.38 78.00 0.61 0.738 N.S.
School. 3.44 3.00 5.40 4.00 4.61 4.00 3.62 0.164 N.S.
Tempev. 5.93 5.00 6.40 6.00 6.19 6.00 0.45 0.798 N.S.
MMSE: mini-mental state examination; School.: schooling in years; TEMPEV.: time of disease evolution; p: significance level; N.S.: not significant.
Table 2 Patients with Alzheimer’s Disease (AD) in Control
Group (CG), Education Group (EG) and Supplementation
Group (SG) compared for CDR, gender and dependence
during meals
CDR Gender Dependence during Meals
1 (n) 2 (n) 3 (n) Male
(n)
Female
(n)
Not dep. Dep.
CG 9 9 9 7 20 14 13
EG 7 11 7 8 17 17 8
SG 7 11 8 10 16 13 13
Total 23 31 24 25 53 44 34
Critical X2 = 5.99 calculated X2 for CDR = 0.77 not significant.
Critical X2 = 5.99 calculated X2 for gender = 0.96 not significant.
Critical X2 = 5.99 calculated X2 for dependence during meals = 2.03 not
significant.
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Table 3 Mean and median values of anthropometric and biochemical measures for patients with Alzheimer’s disease in the different groups
Control Education Supplementation Kruskal-Wallis
Mean Median Mean Median Mean Median Calculated H p Significance
Height 1.57 1.57 1.54 1.54 1.58 1.56 02.20 0.333 N.S.
CW -2.20
(61.87 - 60.65)
-1.81
(57.60 - 55.70)
1.19
(54.29 - 50.00)
0.32
(54.54 - 51.70)
6.66
(54.70 - 57.93)
4.37
(53.55 - 56.80)
22.12 <0.001 S > C and E
BMI -2.21
(24.81 - 24.32)
-1.82
(23.55 - 22.80)
1.19
(22.71 - 22.84)
0.31
(23.82 - 23.90)
6.55
(21.66 - 22.98)
4.37
(22.38 - 23.15)
21.94 <0.001 S > C and E
AC -0.41
(26.14 - 26.07)
0.00
(26.40 - 26.30)
1.87
(24.72 - 25.11)
2.34
(25.60 - 26.00)
5.44
(23.99 - 25.20)
4.76
(23.90 - 24.80)
12.99 0.002 S > C and E
TSF 2.20
(15.67 - 15.85)
0.00
(15.00 - 16.00)
2.32
(14.20 - 16.40)
1.00
(14.00 - 16.00)
1.44
(11.54 - 13.55)
1.58
(12.00 - 14.00)
3.98 0.136 N.S.
AMC -0.19
(21.21 - 21.60)
-0.90
(21.12 - 21.01)
-1.27
(20.25 - 19.96)
-2.06
(19.80 - 19.66)
3.43
(20.36 - 21.01)
2.54
(20.44 - 20.93)
8.67 0.013 S > C and E
Total prot. 0.09
(06.94 - 06.95)
0.00
(07.00 - 06.90)
-1.04
(06.55 - 06.84)
-1.39
(06.80 - 06.80)
4.30
(06.46 - 07.02)
3.28
(06.8 - 07.00)
6.17 0.046 S > C and E
Albumin -3.15
(04.31 - 04.17)
-4.35
(04.30 - 04.10)
-4.06
(04.05 - 04.08)
-4.54
(04.20 - 04.20)
0.69
(03.81 - 04.07)
0.00
(04.20 - 04.20)
2.54 0.281 N.S.
TLC 13.43
(2045.24 - 2279.46)
10.50
(2034.35 - 2416.04)
-1.06
(1888.85 - 1835.25)
-1.41
(1852.40 - 1806.12)
12.57
(1464.20 - 1808.68)
10.68
(1541.10 - 1582.50)
7.94 0.019 S and E > C
CW = Current Weight (kg); BMI = Body Mass Index (Kg/m2); AC = Arm Circumference (cm); TSF = Triceps Skin fold (mm) and AMC = Arm Muscle Circumference (cm); Total prot. = total serum protein (μg/dl); TLC =
Total Lymphocyte Count (mm3); p: significance level; N.S. = not significant
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The addition of 500 kcal/day via oral nutritional supple-
mentation for elderly has been shown to improve conva-
lescence and recovery from deficiency states [23,24].
In relation to the biochemical parameters used to
assess nutritional status, significant differences were only
seen for total protein in the SG and total lymphocyte
count in the SG and EG.
Increased total protein in the SG was not correlated
with the use of oral nutritional supplementation, but this
result may be correlated with evolution of the disease
itself. This parameter could perhaps be better assessed
with a larger sample or longer follow up.
Increased total lymphocyte count (TLC) in the EG sug-
gests that nutrition education might contribute to the
improvement in the immune status of the patients. This
may be due to the influence of education on the choice of
healthier food, which contributes to the nutritional status
as a whole [25].
On the other hand, the significant improvement in
TLC in SG subjects showed that the use of oral nutri-
tional supplementation improves immune status. This
may be due to the antioxidant micronutrients in the
supplement, particularly selenium, b-carotene, vitamin C
and E, which impact with the immune system [26,27].
Improving or maintaining the nutritional status of
patients with AD should be a priority of patient treat-
ment. Therefore this is a responsibility for the entire
multiprofessional team.
Implementing nutrition education improved the BMI of
patients with AD, and thus its use is viable for any kind of
healthcare service due to its low cost and positive impact
on the modification of dietary habits. In addition, oral
nutritional supplementation should be part of the usual
diet of these patients, as the additional nutrients provided
contribute to an improved nutritional status [28,29].
Conclusion
Oral nutritional supplementation was shown to be more
effective compared to nutrition education in improving
nutritional status of patients with Alzheimer’s Disease.
List of abbreviations
ABRAZ: Brazilian Association of Alzheimer’s; AC: Arm Circumference; AD:
Alzheimer’s Disease; AMC: Arm muscle circumference; BMI: Body Mass Index;
CDR: Clinical Dementia Rating; CG: Control Group; DSM IV: Diagnostic
Statistical Manual 4th Edition; EG: Education Group; FOS:
Fructooligosaccharides; g: gram; Kcal: calorie; Kg: kilogram; Kg/m2: kilogram/
meter; mm: millimeters; MMSE: Mini-Mental State Examination; SG:
Supplementation Group; TLC: Total Lymphocyte Count; TP: Total protein;
TSF: Triceps skinfold;
Acknowledgements
We want to acknowledge: CAPES - Ministry of Education and Abbott
Laboratories for their contribution to the realization of this work and the
opportunity given to provide all supplementation that was distributed to all
patients freely.
Author details
1Department Neurology and Neurosurgery, Behaviour Neurology Section,
Universidade Federal de São Paulo/UNIFESP-EPM, São Paulo, Brazil.
2Department of Nutrition, Universidade de Santo Amaro/UNISA, São Paulo,
Brazil.
Authors’ contributions
GP gave classes, nutritional orientations and antropometric measures in all
sample, writing of the article and critically reviewed the article. RS
participated of protocol desing, did cognitive measures and reviewed the
manuscript. YJ and NN carried out of the statistical analysis. IO was
responsible for DA diagnostics. CQ and PH was involved in the protocol and
the study desing, analysis and writing of the article. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 7 June 2011 Accepted: 26 September 2011
Published: 26 September 2011
References
1. Contreras AT: Nutrición em la enfermedad de Alzheimer. Arch Neurocien
2004, 3(9):151-158.
2. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Jernigan T, Archibald S,
Thal LJ: Wheight loss precedes dementia community-dwelling older
adults. J Am Geriatr Soc 1996, 44:1147-1152.
3. Reyes-Ortega G, Guyonnet S, Ousset PJ, Nourhashemi F, Vellas B,
Albarède JL, De Glizezinski I, Riviere D, Fitten LJ: Weight loss in Alzheimer’s
disease and resting energy expenditure (REE), a preliminary report. J Am
Geriatr Soc 1997, 45(11):1365-70.
4. Poehlman ET, Dvorak RV: Energy expenditure, energy intake, and weight
loss in Alzheimer disease. Am J Clin Nutr 2000, , 71: 650S-655S.
5. DiLuca DuW, Growden JH: Weight loss in. Alzheimer’s Disease. J Geriatric
Psychiatry Neurol 1993, 6:34-38.
6. Kikuchi EL, Filho WJ: Tratamento e prevenção de Distúrbios Físicos
associados. In Demência Abordagem Multidisciplinar. Edited by: Caixeta L.
São Paulo: Atheneu; 2006:531-538.
7. Riviere S: Program of nutritional education in the prevention of weight
loss and slow cognitive decline in the disease of Alzheimer. J Nutr Health
Aging 2001, , 5: 295-99.
8. Turano W, Almeida CCC: Educação Nutricional. In: Gouveia ELC. Nutrição
Saúde e Comunidade. 2 edition. Rio de Janeiro: Revinter; 1999, 57-60.
9. Burns BL, Davis EMC: Cuidado Nutricional nas Doenças do Sistema
Nervoso. In:Mahan LK, Stump SE. Alimentos, Nutrição e Dietoterapia. 9
edition. São Paulo: Roca; 1998, 896-7.
10. Borges VC: Repercussão Nutricional nas Doenças Neurológicas da
Velhice: Alzheimer e Parkinson. [texto na internet]. Nutrição Total São
Paulo. Disponível em; 2003 [http://www.nutritotal.com.br].
11. Chumlea WC, Roche AF, Steinbaugh ML: Estimating stature from knee
height for persons 60 to 90 years of age. J Am Geriatric Soc 1985, , 33:
116-120.
12. Folstein MF, Folstein SE, McHugh PR: Mini-mental state. A practical
method for grading the cognitive state of patients for the clinician.
J Psychiatr Res 1975, 12:189-198.
13. Bertolucci PHF, Brucki SMD, Campacci SR, Juliano Y: O mini-exame do
Estado Mental em uma população geral. Impacto da escolaridade. Arq
Neuropsiq 1994, 52:1-7.
14. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical
scale for the stating of dementia. British Journal of Psychiatry 1982,
140:556-572.
15. Morris JC: The Clinical Dementia Rating (CDR): current version and
scoring rules. Neurology 1993, 43:2412-2414.
16. Caovilla VP, Canineu PR: Você não está sozinho ABRAZ. São Paulo: ABRAZ;
2002.
17. Muñoz AM, Agudelo GM, Lopera FJ: Diagnóstico del estado nutricional de
los pacientes con demencia tipo Alzheimer registrados en el Grupo de
Neurocienciais, Medellín, 2004. Biomédica 2006, 1(26):113-125.
18. Boog MCF: Educação nutricional em serviços públicos de saúde. Cad
Saúde Pública 1999, 2(15):S139-S147.
Pivi et al. Nutrition Journal 2011, 10:98
http://www.nutritionj.com/content/10/1/98
Page 5 of 6
19. Cervato AM, Dernti AM, Latorre MRDO, Marucci MFN: Educação nutricional
para adultos: uma experiência positiva em Universidade Aberta para a
Terceira Idade. Rev Nutr 2005, 18(1):41-52.
20. Carver AD, Dobson AM: Effects of dietary supplementation of elderly
demented hospital residents. J hum Nutr Diet 1995, , 8: 389-94.
21. Faxen-Irving G, Andren-Olsson B, Geirjerstam AF, Basun H, Cederholm T:
The effect of nutritional intervention in elderly subjects residing in
group-living for the demented. Eur Jour of clinical 2002, 56(3):221-27.
22. Trelis JJB, López IF: La Alimentación del enfermo de Alzheimer en el
âmbito familiar. Nutr Hosp 2004, , 19: 154-59.
23. Lauque S, Battandier FA, Mansourian R, Guigoz Y, Paintin M: Nourhashemi
F, et al. Protein-energy oral supplementation in malnourished nursing-
home residents. A controlled trial. Age and Ageing 2000, , 29: 51-6.
24. Volkert D, Hubsch S, Oster P: Nutritional support and functional status in
undernourished geriatric patients during hospitalization and 6 months
follow-up. Aging Clin Exp Res 1996, , 8: 386-95.
25. Norregaard O, Tottrup A, Saaek A: Effects of oral nutritional supplements
on adults with chronic obstructive pulmonary disease. Clin Resp Physiol
1987, , 23: 388.
26. Sampaio ARD, Mannarino IC: Medidas bioquímicas de avaliação do
estado nutricional. In Avaliação Nutricional: Aspectos Clínicos e Laboratoriais.
Edited by: Duarte ACG. São Paulo: Atheneu; 2007:69-73.
27. Roebothan BV, Chandra RK: Relationship between Nutritional Status and
Immune Function of Elderly People. Age Ageing 1994, , 23: 49-53.
28. Spindler AA, Renvall MJ, Nichols JF, Ramsdell JW: Nutritional Status of
Patients with Alzheimer’s Disease: A 1-Year Study. J AM Diet Assoc 1996,
10(96):1013-1018.
29. Fonseca AM, Soares E: Interdisciplinaridade em grupos de apoio a
Familiares e Cuidadores do Portador da Doença de Alzheimer. Rev Saúde
Com 2007, 3(1):3-11.
doi:10.1186/1475-2891-10-98
Cite this article as: Pivi et al.: A prospective study of nutrition education
and oral nutritional supplementation in patients with Alzheimer’s
disease. Nutrition Journal 2011 10:98.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Pivi et al. Nutrition Journal 2011, 10:98
http://www.nutritionj.com/content/10/1/98
Page 6 of 6
